21 CFR Part 11: (Un)Expected Added Value

Dillon,Ralph;Noferi,Joseph;Worden,Daniel;

21 CFR Part 11: (Un)Expected Added Value

Published on: February 15, 2002

Ralph L. Dillon, Joseph F. Noferi, Esq., Daniel E. Worden

BioPharm International, BioPharm International-02-01-2002, Volume 15, Issue 2

Pages: 44-50

By Joseph F. Noferi, Esq., Ralph Dillon, and Daniel E. Worden, pp. 44-50. Implementing the ERES rule will do more than make your organization compliant with federal regulations. It will strengthen its intellectual property position for the information age.